血浆脂联素水平与冠脉病变及PWV、ABI的关系研究
|
摘要
目的血清脂联素(adiponectin,APN),一种脂肪组织来源的胶原样血浆蛋白,具有抗动脉粥样硬化,抗炎及改善胰岛素敏感性等作用;脉搏波传导速度(pulsewave velocity,PWV)指的是脉搏波在动脉的传导速度;ABI指的是上臂血压与脚踝血压的比值。本研究旨在观察冠心病(CHD)患者血浆脂联素(APN)水平,测量踝臂指数(ABI)和脉搏波传导速度(PWV)并探讨它们与冠脉病变之间的关系,尤其他们在冠心病诊断中的价值与意义。
方法选取在本院心内科行冠脉造影的住院病人88例,43例诊断为ACS,22例诊断为稳定性心绞痛(SAP);23例冠脉造影正常者为对照组;采用酶联免疫法检测血浆APN水平,动脉硬化检测仪检测ABI,PWV。分别根据冠心病严重程度,冠脉造影结果,PWV值和ABI值进行分组,比较各组间APN,PWV,ABI的关系。
结果
1(1)APN水平:ACS组APN水平低于正常对照组(P＜0.01)及SAP组(P＜0.01),SAP组APN水平低于正常对照组(P＜0.01);
(2)PWV水平:冠心病组高于正常对照组(P＜0.01),ACS组高于SAP组(P＜0.01)SAP组高于正常对照组(P＜0.01),差异有统计学意义;
(3)ABI水平:ACS组低于正常对照组和SAP组(P＜0.01),SAP组与正常对照组相比差异无统计学意义。
2(1)经冠脉造影证实的冠心病组APN水平低于正常对照组(P＜0.01),其中三支病变组APN水平低于健康对照组和单支病变组及双支病变组,差异有统计学意义;双支病变组血浆脂联素水平低于单支病变组(P＜0.05),差异有统计学意义。
(2)ABI水平三支病变组ABI水平低于健康对照组,一支病变组(P＜0.01),低于双支病变组(P＜0.05);双支病变组低于健康对照组及单支病变组(P＜0.01);单支病变组与健康对照组间差异无统计学意义(P＞0.05)。
(3)PWV水平,单支病变组与正常对照组差异五统计学意义(P＞0.05),其他各组间差异有统计学意义(P＜0.01)。
3患者入院后测PWV值,其中＜1400cm/s,27人,1400cm/s～1800cm/s,32人,PWV＞1800cm/s,29人,比较PWV各个值段的患者APN水平。各组间差异均具有统计学意义(P＜0.01)。
4比较不同ABI值患者的APN水平发现,以ABI=0.9为界,ABI＜0.9组患者APN水平低于ABI＞0.9组,PWV水平高于ABI＞0.9组,P＜0.01。
结论
(1)冠心病患者血浆APN水平明显降低,PWV升高,ABI降低;
(2)冠心病患者血浆APN水平越低,PWV值越大,ABI水平也越低。
(3)血浆APN水平的降低与冠脉狭窄程度,冠脉斑块的易损性有密切关系。APN可能是冠心病的一个新的独立危险因子,可作为冠心病情变化的标志之一
(4)APN与ABI、PWV联合在冠心病的早期诊断,冠心病患者冠脉病变程度及危险性的评估及对冠心病患者预后方面的预测具有重要意义。
(5)动态监测血清脂联素,PWV,ABI水平有可能成为早期诊断冠心病,观察病情,判断预后的一个指标。
Objective Adiponectin(APN) is a kind of lipoaspiration-derived collagenase-like plasma protein,which could be anti-antiatherogenic,antiphlogistic and improve the sensibility of insulin.To investigate the variation of plasma adiponectin(APN),the ankle brachial index(ABI),and the pulse wave velocity(PWV) in patients with the coronary heart disease(CHD) and explore the correlation between them,especially the meaning and of those to the diagnosis of CHD.
Methods A total of 98 subjects who attended the cardiovascular department of the affiliated hospital of Qingdao university medical college from Aug 2007 to Jun 2008 were enrolled.The subjects were divided into normal control group(n=23),the ACS group(n=43) and the SAP group(n=22) by angiography.Serum concentrations 'of adiponctin were evaluated by ELISA system,the the ABI and the PWV were tested by the non-invasive vascular screening device.Grouped the patients by type of CHD, the result of coronary arteriongraphy PWV and ABI.Compared the APN,PWV,ABI of each group.
Results The APN of ACS group was lower than that of normal group and SAP group.while the APN of SAP group was lower than that of normal group.The PWV of CHD group was higher than that of normal group,the ACS group was higher than that of SAP group and normal group,SAP group was higher than normal group,the difference was of statistical significance.The ABI of ACS group was lower than that of normal group and SAP group,the difference of SAP group and normal group was of no statistical significance.The APN of CHD group was lower than that of normal group,the trifurcate vessel diseased group was lower than normal group,single vessel diseased group and double vessel diseased group.the double vessel diseased group was lower than that of single vessel diseased group and the normal group.There was statistical significance in every two group but the single vessel diseased group and the normal group.The ABI of the trifurcate vessel diseased group was lower than normal group,single vessel diseased group,and double vessel diseased group.the double vessel diseased group was lower than that of single vessel diseased group and the normal group.there was no statistical significance between single vessel diseased group and normal group.Tested the PWV of patients and grouped them by the PWV,there was 27 patients in PWV＜1400cm/s group,32 patients in 1400cm/s～1800cm/s group,29 patients in PWV＞1800cm/s group,compared the APN and ABI of each group,there was statistical significance between every two groups.Grouped patients by ABI,compared the APN and PWV of every two groups,the APN of ABI＜0.9 group was lower than that of ABI＞0.9 group and the PWV higher was higher.
Conclusion The plasma APN levels are significantly lower in patients with CHD,the PWV is higher,the ABI is lower.The PWV will be higher and the ABI will be lower,while the APN of CHD patients decrease.The levels of plasma APN has close relationship with the severity of coronary artery stenosis,the stability of atherosclerotic lesion.The APN,ABI and PWV might be new risk factors of CHD, and provide a new and convenient way for us to evaluate and diagnose the severity of coronary artery diseaseDynamic monitoring of APN,PWV and ABI maybe provide a new way of CHD early diagnosis,pathogenetic condition monitoring and prognosis judgement for the clinician.
方法选取在本院心内科行冠脉造影的住院病人88例,43例诊断为ACS,22例诊断为稳定性心绞痛(SAP);23例冠脉造影正常者为对照组;采用酶联免疫法检测血浆APN水平,动脉硬化检测仪检测ABI,PWV。分别根据冠心病严重程度,冠脉造影结果,PWV值和ABI值进行分组,比较各组间APN,PWV,ABI的关系。
结果
1(1)APN水平:ACS组APN水平低于正常对照组(P＜0.01)及SAP组(P＜0.01),SAP组APN水平低于正常对照组(P＜0.01);
(2)PWV水平:冠心病组高于正常对照组(P＜0.01),ACS组高于SAP组(P＜0.01)SAP组高于正常对照组(P＜0.01),差异有统计学意义;
(3)ABI水平:ACS组低于正常对照组和SAP组(P＜0.01),SAP组与正常对照组相比差异无统计学意义。
2(1)经冠脉造影证实的冠心病组APN水平低于正常对照组(P＜0.01),其中三支病变组APN水平低于健康对照组和单支病变组及双支病变组,差异有统计学意义;双支病变组血浆脂联素水平低于单支病变组(P＜0.05),差异有统计学意义。
(2)ABI水平三支病变组ABI水平低于健康对照组,一支病变组(P＜0.01),低于双支病变组(P＜0.05);双支病变组低于健康对照组及单支病变组(P＜0.01);单支病变组与健康对照组间差异无统计学意义(P＞0.05)。
(3)PWV水平,单支病变组与正常对照组差异五统计学意义(P＞0.05),其他各组间差异有统计学意义(P＜0.01)。
3患者入院后测PWV值,其中＜1400cm/s,27人,1400cm/s～1800cm/s,32人,PWV＞1800cm/s,29人,比较PWV各个值段的患者APN水平。各组间差异均具有统计学意义(P＜0.01)。
4比较不同ABI值患者的APN水平发现,以ABI=0.9为界,ABI＜0.9组患者APN水平低于ABI＞0.9组,PWV水平高于ABI＞0.9组,P＜0.01。
结论
(1)冠心病患者血浆APN水平明显降低,PWV升高,ABI降低;
(2)冠心病患者血浆APN水平越低,PWV值越大,ABI水平也越低。
(3)血浆APN水平的降低与冠脉狭窄程度,冠脉斑块的易损性有密切关系。APN可能是冠心病的一个新的独立危险因子,可作为冠心病情变化的标志之一
(4)APN与ABI、PWV联合在冠心病的早期诊断,冠心病患者冠脉病变程度及危险性的评估及对冠心病患者预后方面的预测具有重要意义。
(5)动态监测血清脂联素,PWV,ABI水平有可能成为早期诊断冠心病,观察病情,判断预后的一个指标。
Objective Adiponectin(APN) is a kind of lipoaspiration-derived collagenase-like plasma protein,which could be anti-antiatherogenic,antiphlogistic and improve the sensibility of insulin.To investigate the variation of plasma adiponectin(APN),the ankle brachial index(ABI),and the pulse wave velocity(PWV) in patients with the coronary heart disease(CHD) and explore the correlation between them,especially the meaning and of those to the diagnosis of CHD.
Methods A total of 98 subjects who attended the cardiovascular department of the affiliated hospital of Qingdao university medical college from Aug 2007 to Jun 2008 were enrolled.The subjects were divided into normal control group(n=23),the ACS group(n=43) and the SAP group(n=22) by angiography.Serum concentrations 'of adiponctin were evaluated by ELISA system,the the ABI and the PWV were tested by the non-invasive vascular screening device.Grouped the patients by type of CHD, the result of coronary arteriongraphy PWV and ABI.Compared the APN,PWV,ABI of each group.
Results The APN of ACS group was lower than that of normal group and SAP group.while the APN of SAP group was lower than that of normal group.The PWV of CHD group was higher than that of normal group,the ACS group was higher than that of SAP group and normal group,SAP group was higher than normal group,the difference was of statistical significance.The ABI of ACS group was lower than that of normal group and SAP group,the difference of SAP group and normal group was of no statistical significance.The APN of CHD group was lower than that of normal group,the trifurcate vessel diseased group was lower than normal group,single vessel diseased group and double vessel diseased group.the double vessel diseased group was lower than that of single vessel diseased group and the normal group.There was statistical significance in every two group but the single vessel diseased group and the normal group.The ABI of the trifurcate vessel diseased group was lower than normal group,single vessel diseased group,and double vessel diseased group.the double vessel diseased group was lower than that of single vessel diseased group and the normal group.there was no statistical significance between single vessel diseased group and normal group.Tested the PWV of patients and grouped them by the PWV,there was 27 patients in PWV＜1400cm/s group,32 patients in 1400cm/s～1800cm/s group,29 patients in PWV＞1800cm/s group,compared the APN and ABI of each group,there was statistical significance between every two groups.Grouped patients by ABI,compared the APN and PWV of every two groups,the APN of ABI＜0.9 group was lower than that of ABI＞0.9 group and the PWV higher was higher.
Conclusion The plasma APN levels are significantly lower in patients with CHD,the PWV is higher,the ABI is lower.The PWV will be higher and the ABI will be lower,while the APN of CHD patients decrease.The levels of plasma APN has close relationship with the severity of coronary artery stenosis,the stability of atherosclerotic lesion.The APN,ABI and PWV might be new risk factors of CHD, and provide a new and convenient way for us to evaluate and diagnose the severity of coronary artery diseaseDynamic monitoring of APN,PWV and ABI maybe provide a new way of CHD early diagnosis,pathogenetic condition monitoring and prognosis judgement for the clinician.
引文
[1]MatsudaM,Shimomura I,Sata M,et al.Role of adiponectin in p reventing vascular stenosis - The missing link of adipo - vascular axis [J].J Biol Chem.2002,277(40):37487-91.
[2]Ishikawa Y,Akasaka Y,Ishii T,et al.Changes in the distribution pattern of gelatin2binding p rotein of 28 kda(adiponectin) in myocardial remodeling after ischaemic injury[J].Histopathology,2003,42(1):43.
[3]刘岩,邹大进,李慧,等.低脂联素血症是冠状动脉粥样硬化严重程度的重要标志[J].中华内分泌代谢杂志,2005,21(1:5-8)
[4]Pischon T,Girman CJ,Hotamisligil GS,et al.Plasma adiponectin levels and risk of myocardial infarction in men[J].JAMA,2004,291(14):1730-1737.
[5]KumadaM,Kihara S,Sumitsuji S,et al.Association of hypoadipone2Ctinemia with coronary artery disease in men[J].Arterioscler Thromb Vasc Biol,2003,23(1):85-89.
[6]胡大一.重视踝臂指数,关注下肢外周动脉病[J].中国医药导刊,2005,7(1):29.
[7]Kumada M,Kihara S,Sumitsuji S,et al.Association of hypoadiponettinemia with coronary artery disease in men[J].Arterioscler Thromb Vasc Biol,2003;23(1):85-9.
[8]郭杰,常志文。冠心病不同兵变支数与血清脂联素的相关性[J]。临床荟萃,2005;20(11):607-609。
[9]Kumada M,Kihara S,Ochi N,et al,Adioonectin specifically increased tissue inhibitor of metallo proteinase-1 through interleukin-10 expression in human macrophages[J].Circulation,2004;109(17):2046-9.
[10]Ouchi N,Kihara S,Arita Y,et al.Adiponectin,an adipocyte-derived plasma protein,inhibit s endothelial NF-kap-paB signaling through a cAMP-dependent pathway[J].Circulation,2000,102:1296
[11]Arita Y,Kihara S,Ouchi N,et al.Paradoxial decrease of an adipose spicific protein,adiponectin,in obesity[J].Biochem Biophys Res Commun,1999,257:79
[12]Yokota T,Oritani K,Takahashi I,et al.Adiponectin,a new member of the family of soluble defense collagens,negatively regulates the growth of myelomonocytic progenitiors and the functions of macrophages[J]Blood,2000,96:1723
[13]Ouchi N,Kihara S,Arita Y,et al.Adipoce-derived plasma protein,adiponectin,suppresses lipid accumulation and class A scavenger receptor expression in human monocyte2dedved macrophages[J].Circulation,2001,103:1057
[14]Mat suda M,Shimomural I,Sata M,et al.Role of adiponectin in preventing vascular stenosis:the missing linkof adipo-vascular axis[J].J Biol Chem.
[15]刘岩,邹大进,李慧,陈月,丁继军,郑兴,等.低脂联素血症是灌装动脉粥样硬化程度的重要标志[J].中华内分泌代谢杂志,2005,21(1):528
[16]Ouchi N,Kiharn S,Amta Y,et al.Adiponectin,an adipocyte-derived plasma protein,inhibit s endot helial NF2κB signalingt hrough a cAMP2dependent pathway.Circulation,2000,102(11):1296-1301
[17]Kumada M,Kihara S,Sumit suji S,et al.Association of hypoadiponectinemia wit h coronary artery disease in men.Arteriosc ler Thromb Vasc Biol,2003,23(1):85-89.
[18]Nakamura Y,Shim ada K,Fukuda D,et al.Implications of plasma concentions of adiponectin in patient s wit h coronary artery disease.Heart,2004,90(5):528-533.
[19]Nakamura Y,Shimada K,Fukuda D,et al.Implications of plasma concentrations of adiponectin in patients with coronary artery disease[J].Heart(British Cardiac Society),2004,90(5):5282533.
[20]Pischon T,Girman CJ,Hotamisligil GS,et al.Plasma adiponectin levels and risk of myocardial infarction in men[J].JAMA,2004,291(14):1730-1737.
[21]Zoccali C,Mallamaci F,Tripepi G,et al.Adiponectin,metabolic risk factors,and cardiovascular events among patients with end2stage renal disease[J].J Am Soc Nephrol,2002,13(1):134-141.
[22]Schulze MB,Shai I,Rimm EB,et al.Adiponectin and future coronary heart disease events among men with type 2 diabetes[J].Diabetes,2005,54(2):534-539.
[23]Nakamura Y,Shimada K,Fukuda D,Shimada Y,Ehara S,Hirose M,et al.Implications of plasma concentrations of adiponectin in patients with coronary artery disease[J].Heart,2004,90(5):528-533.
[24]刘叶,于晓玲,不同类型冠心病患者血清脂联素水平及冠心病危险因素的变化,[J].中国心血管病研究杂志,2006,4(4):287-289
[25]Date H,Imamura T,Ideguchi T,Kawagoe J,Sumi T,Masuyama H,et al.Adiponectin produced in coronary circulation regulates coronary flow reserve innondiabetic patients with angiographically normal coronary arteries[J].ClinCardiol,2006,29(5):211-214.
[26]BenetosA.Pulse p ressure and cardiovascular risk[J].JHyperLens,1999,17(supp 15):S21-24.
[27]胡大一,王宏宇.亚临床血管病变与临床实践(上)[J].中国医刊,2002,37(12):40-42.
[28]胡大一,王宏宇.亚临床血管病变与临床实践(下)[J].中国医刊,2003,38(1):52-54.
[29]Glasser SP,Amett DK,McVeigh GE,et al.Vascularcomp liance and cardiovascular disease:a risk factor ormarker[J].Am JHY - pertens,1997,10:1175-1189.
[30]Asmar R,Rudnichi A,Blacher J,et al.Pulse pressure and aortic pulsewave are markers of cardiovascular risk in hypertensive populations[J].AJH,2001,14:91-97.
[31]Zakopoulos NA,Lekakis JP,Papamichael CM,et al.Pulse pressure in normotensives:a marker of cardiovascular disease[J].Am J Hypertens, 2001,14(30):195-199.
[32]Yamashina A,Tomiyama H,Arai T,et al.Brachialankle pulse wave velocity as a marker of arherosclerotic vascular damage and ardiovascular risk[J].Hypertens Res,2003.26(8):615-622.
[33]Michael J,Domanski MD,Kim Sutton Tyrrell,et al.Determinant sand prognosticin formation provided by pulse pressure in patients with coronary artery disease under going revascularization(the balloon angio plasty revascularization investigation[J].Am J Cardiol,2001,87(6):675-679.
[34]Anar T,Ruidlavets J,Chamontin B,et al.Arterial stiffness and cardiovascular risk factors in a population based study[J].J Hypertens,2001,19(3):381-387
[35]Blather J,Asmar R,Djane S,et al.Aortic pulse wave velocity as a marker of cardiovascular risk in hypertension patients[J].Hypertension,1999,33:1111-1117.
[36]Meanme S,Benclos A,Hemv OF,et al.Aorlic pulse wave velocity predicts cardiovascular modality in subjects>70 years of age[J].Aterioscacler Thromb Vase Biol,2001,21(12):2046-2050.
[37]Blather J,Pannier B,Guerin AP,et al.CAROTID arterial stiffness as a predictor of cardiovascular and all cause mortality in end stage renal disease[J].Hypertension,1998,32(3):570-574
[38]Cleem JL.Executive summary of the third report of the National Cholesterol Education Program(NCEP) expert panel detection,evaluation,and treatment of high blood cholesterol in adults(adult treatment panel Ⅲ)[J].JAMA,2001,285(19):2486-2497.
[39]Abbott RD,Petrovich H,Rodriguez BL,et al.Ankle /brachial blood p ressure in men > 70years of age and the risk of coronary heart disease[J].Am J Cardiol,2000,86:280-284.
[40]Chuang SY,Chen CH,Cheng CM,et al.Combined ues of brachial2ankel pulse wave velocity and ankle2brachial index for fast assessment of arteriosclerosis and atherosclerosis in a community[J].Int J Cardiol,2005,98:99-105.
[41]王昆,胡大一,杨进刚,等.1 008例有心血管危险因素患者踝臂指数异常的发生率及其相关因素[J].首都医科大学学报,2006,27(4):4992511.
[42]韩雅蕾,胡大一.踝臂指数对冠心病患者冠状动脉粥样硬化及心血管事件的预测价值[J].中国民康医学杂志,2006,18:340-343.
[43]Lee AJ,Price JF,RussellMJ,et al.Imp roved p redition of fatalmyocardiaol infarction using the ankle brachial index in addition to conventional risk factors:The Edinburgh Artery Study[J].Circulation,2004,110:3075-3080.
[44]CriquiMH,Langer RD,Fronek A,et al.Mortality over a period of 10 year inpatientswith peripherial arterial disease[J].N Engl J Meal,1992,326:381-386.
[45]ChristosMP,Lekakis JP,Stamtelopoulos KS,et al.Ankle2brachial index as a predictor of the extent of coronary atherosclerosis and cardiovascular events in patientswith coronary artery disease[J].Am J Cardiol,2000,86:615-618.
[46]Kenneth E,AtulM,Eseroghene O,et al.U sefulness of an abnomal ankle-brachial index to p redict p resence of coronary artery disease in African-Americans[J].Am J Cardiol,2004,93:481-483.
[47]杨士伟,胡大一.踝臂指数对冠状动脉狭窄程度的预测价值[J].中国医药导刊,2006,8(2):79-82.
[48]Doobay AV,Anand SS.Sensitivity and specificity of the ankle2brachial index to predict future cardiovascular outcomes:a systematic review[J].Arterioscler Thromb Vasc B iol,2005,25:1463-1469.
[49]Hooi JD,Kester ADM,Stoffers HEJH,et al.Asymp tomatic peripheral arterial occlusive disease p redicted cardiovascular morbidity and mortality in a 72yearfollow-up study[J].J Clin Ep idemiol,2004,57:294-300.
[50]Resnick H,L indsay R.Relationship of high and low ankle2brachial index to all-cause and cardiovascular disease mortality[J].Circulation,2004,109:733-739.
[51]CriquiMH,Langer RD,Froneck A,et al.Mortality over a period of 10 years in patientswith peripheral arterial disease[J].N Engl J Med,1992,326:381-386.
[52]RutterMK,Wahid ST,McComb JM,et al.Significance of silent ischemia and microalbuminuria in p redicting coronary events in asymp tomatic patients with type 2diabetes[J].J Am Coll Cardiol,2002,40(1):56-61.
[53]CriquiMH,Fronek A,Barrett2Connor E,et al.The p revalence of peripheral arterial disease in a defined population[J].Circulation,1985,71:510-515.
[54]王宏宇,张维忠,龚兰生,等.脉搏波传导速度测定的新认识[J].国外医学.心血管疾病分册,2000,27(2):70-72.
[55]王国彦,胡大一.高血压患者大动脉弹性对冠状动脉血流储备的影响[J].中华医学杂志,2005,5(1):54-57.
[56]李佳月.脉搏波传导速度测定的临床意义[J].国际心血管病杂志,2006,33(2):91-93.
[57]MEAUME S,BENETOS A,HENRY O F,et al.Aortic pulse wave velocity predicts cardiovascular mortality in subjects> 70 years of age[J].Aterioscler Thromb Vase Biol,2001,21(12):2046- 2050.
[58]胡大一.重视踝臂指数,关注下肢外周动脉病[J].中国医药导刊,2005,7(1):29.
[1]李晓燕,王铁成,刘世雷.血浆脂联素与冠心病患者炎性因子水平的关系分析[J].中国心血管病研究,2007,5(8):584-585.
[2]李嘉强,戴颖秀,刘玉敏,等.高血压患者血浆脂联素与游离脂肪酸,糖及脂代谢[J].中华高血压杂志,2006,14:352-355
[3]TanKC,XuA,ChowWS,etal.Hypoadiponectinemiaisassociatedwithimpairedendothelium-depend entvasodilation[J].JClinEndocrinolMetab,2004,89:675-769
[4]KobayashiH,OuchiN,kiharaS,etal.Selectivesuppressionofendothelialcellapoptosisbythehighmol ecularweightformofadiponectin[J].CircRes,2004,94:E27-31
[5]YamauchiT,KamonJ,WakiH,etal.GluoaradiponectinprotectedobPobmicefromdiabetesandApoE -deficientmicefromatherosclerosis[J].JBiolChem,2003,278:2461-2468.
[6]Mat suzawa Y,Funahashi T,Nakamura T,et al.Molecularmechanism of metabolisyndrome of adipocytokines adipocyte-derived bioactive substances.Ann N Y Acad,1999,892:146-154.
[7]Maeda K,Okubo K,Shimomura I,Funahashi T,Matsuzawa Y,Matsubara K.cDNA cloning and expression of an novel adipose2specific collagen2like factorapM1(adipose most abundant gene transcript1)[J].Biochem Biophys Res Commun,1996,221(2):286-289.
[8]Hara K,Boutin P,Mori Y,Tobe K,Dina C,Yasuda K,et al.Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2diabetes in the Japanese Population[J].Diabetes,2002,51(2):536-540.
[9]Pajvani UB,Du X,Combs TP,et al.Structure function studies of the adipocyte-secreted hormone Acrp30Padiponectin:implications for metabolic-regulation and bioactivity[J].JBiol Chem,2003,278(11):9073-9085.
[10]Pajvani UB,HawkinsM,Combs TP,et al.Complex distribution,not absolute amount of adiponectin,correlates with thiazolidinedione-mediated improvement in insulin sensitivity[J].J Biol Chem,2004,279(13):12152-12162.
[11]Kobayashi H,Ouchi N,Kihara S,et al.Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin[J].Circ Res,2004,94(4):27-31.
[12]Aso Y,Yamamoto R,Wakabayashi S,Uchida T,Takayanagi K,Takebayashi K,et al.Comparison of serum high2molecular weight(HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme2linked immunosorbent assay to detect HMW adiponectin[J].Diabetes,2006,55(7):1954-960.
[13]Yamauch i T,Kamon J,Ito Y,et al.Cloning of adiponectin recep to rs that mediate antidiabetic metabo lic effects[J].N ature,2003,423(6941):762-769.
[14]Ohash i K,Ouch i N,Kihara S,etal.A diponectin I 164Tmutation is associated w ith the metabo lic syndrome and coronary artery disease[J].J Am Co 11 Cardio 1, 2004, 43 (7):1195-1200.
[15]Ouchi N , Kihara S , Funahashi T , et al.Reciprocal association of Creactive protein with adiponectin in bloodst ream and adipose tissue.Circulation , 2003 ,107 (5):671-674.
[16]Kato H , Kashiwagi H , Shiraga M ,et al.Adiponectin act s as an endogenous antit hrombotic factor.Arterioscl Thromb Vase Biol ,2006,26 (1):224-230.
[17]Hulthe J , Hulten LM, Fagerberg B.Low adipocyte2derived plasma protein adiponectin concentrations are associated with the metabolic syndrome and smalldense low-density lipoprotein particles:Atherosclerosis and insulin resistance study [J].Metabolism, 2003 ,52 (12):1 612-614.
[18]Maeda N,Shimomura I,Kishida K, Nishizawa H , Matsuda M, Nagaretani H ,et al.Diet-induced insulin resistance in mice lacking adiponectinPACRP30[J ].Nat Med , 2002 , 8:731-737.
[19]Hotta K, Funahashi T, Bodkin NL , Ortmeyer HK, Arita Y, Hansen BC, et al.Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys [J].Diabetes , 2001, 50:1126-133.
[20]Araki T, Emoto M, Teramura M, Yokoyama H , Mori K, Hatsuda S , et aLEffect of adiponectin on carotid arterial stiffness in type 2 diabetic patients treated with pioglitazone and metformin [J ].Metabolism , 2006 ,55 (8):996-1001.
[21]Iwaki M, Matsuda M, Maeda N , Funahashi T, Matsuzawa Y, Makishima M,et al.Induction of adiponectin ,a fat2derived antidiabetic and antiatherogenic factor , by nuclear receptors [J ].Diabetes, 2003 ,52 (7):1 655-663.
[22]Adamczak M, Wiecek A, Funahashi T, Chudek J , Kokot F, Matsuzawa Y.Decreased plasma adiponectin concentration in patients with essential hypertension [J ].Am J Hypertens , 2003 , 16 (1):72-75.
[23]Fasshauer M, Klein J , Neumann S , Eszlinger M, Paschke R.Adiponectin gene expression is inhibited by beta-adrenergic stimulation via protein kinase A in 3T32L1 adipocytes [J ].FEBS Lett, 2001,507 (2):142-146.
[24]Shimabukuro M, Higa N , Asahi T, Oshiro Y, Takasu N ,Tagawa T, et al.Hypoadiponectinemia is closely linked to endothelial dysfunction in man [J ].JClin Endocrinol Metab, 2003 ,88 (7):3 236-240.
[25]Otsuka F, Sugiyama S, Ko jima S, et al.Plasma adiponectin levels are associated w ith co ronary lesion comp lexity in men w ith co ronary artery disease[J ].J Am Coll Cardio 1; 2006, 48 (6):1155-1162.
[26]Kato H, Kash iwagi H, Sh iragaM , et al.A diponectin act as anendogenous antith rombo tic facto r [J ].A rterio scler Th romb V ascBio 1,2006,26 (1):224-230.
[27]马建林,李新明,王圣,等．不稳定型心绞痛患者体内凝血因子1的变化及意义[J]．临床 心血管病杂志,2006,22(2):121-122
[28]OUCHI N,KIHARA S,ARITA Y,et al.Adipocyte-derived plasma protein,adiponectin,suppresseslipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages[J].Circulation,2001,103:1057-1063.
[29]MATSUDA M,SHIMOMURA I,SATA M,et al.Role of adiponectin in preventing vascular senosin[J].J Biol Chem,2002,277:37487-37491.
[30]岳夏,吴华,陈新山.炎症与急性冠脉综合征的研究进展[J].临床心血管病杂志,2005,21(6):378-380
[31]Okamoto Y,Kihara S,Ouchi N,Nishida M,Arita Y,Kumada M,et al.Adiponectin reduces atherosclerosis in apolipoprotein Edeficient mice [J].Circulation,2002,106(22):2 767-770.
[32]FRUEBIS J,TSAO T S,JAVORSCHI S,et al.Proteolytic cleavage product of 302KDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice[J].Proc NatAcad Sci USA,2001,98:2005-2010.
[33]YAMAUCHI T,KAMON J,MIZO KOSHI Y,et al.Adiponectin stimulates glucose utilization and fattyacid oxidation by activating AMP2activated protein kinase[J].Nat Med,2002,8:1288-1295.
[34]YAMAUCHI T,KAMON J,WA KI H,et al.Globular adiponectin protected ob/ob mice f rom diabetesand Apo E2deficient mice from atherosclerosis[J].J Biol Chem,2003,278:2461-2468.
[35]Kawanam i D,M aemura K,Takeda N,et al.D irect recip rocal effects of resistin and adiponectin on vascular endo thelial cells:a new insigh t into adipocytok ineendo thelial cell interactions[J].Biochem Biophys Res Commun,2004,314:415-419.
[36]L in L Y,L in CY,Su TC,et al.A ngio tensin II induce dapop to sisin human endo thelial cells is inh ibited by p ro tein90[J].FEBS L ett,2004,574(13):106-110.
[37]M anigrasso MR,Ferroni P,Santilli F,et al.Association between circulating adiponectin and interleuk in210 levels in android obesity:effects of weigh t lo ss[J].J Clin Endocrino l M etab,2005,90:5876-5879.
[38]Wo lf AM,Wo lf D,Rumpo ld H,et al.A diponectin induces the anti inflammato ry cytokines IL 210 and IL 21RA in human leukocytes[J].Biochem Biophys Res Commun,2004,323:630.
[39]Peake PW,Shen Y,Campbell LV,et al.Human adiponectin binds to bacterial lipopo lysaccharide[J].Biochem Biophys Res Commun,2006,341(1):108-115.
[40]Ekmekci,H,Ekmekci,OB.The ro le of adiponectin in athero sclero sis and th rombosis[J].Clin-Appl-Thromb-Hemo st,2006,12(2):163-168.
[41]Okamo to Y,Kihaya S,Ouchi N,et al.A diponectin reduces athero sclero sis in apo lipop ro tein Edeficient m ice[J].Circulation,2002,106(22):2767-2770.
[42]Diep linger B,Poelz W,Haltmayer M,et al.Hypoadiponectinem ia is associated w ith symp tomatic athero sclero tic peripheral arterial disease[J].Clin Chem Lab Med,2006,44(7):830-833.
[43]Beh re CJ,Brohall G,Hulthe J,et al.A reserum adiponectin concentrations in a population samp le of 64-year-old Caucasian women w ith varying gluco seto lerance associated with ultrasound-assessed athero sclerosis[J].J Intern Med,2006,260(3):238-244.
[44]刘岩,邹大进,李慧,陈月,丁继军,郑兴,等.低脂联素血症是灌装动脉粥样硬化程度的重要标志[J].中华内分泌代谢杂志,2005,21(1):5-8
[45]Ishikawa Y,Akasaka Y,Ishii T,Yoda Murakami M,Choi Miura NH,Tomita M,et al.Changes in the distribution pattern of gelatin -binding protein of 28kDa(adiponectin) in myocardial remodelling after ischaemic injury[J].Histopathology,2003,42(1):43-52.
[46]Karakitsos D,De Groot E,Patrianakos AP,Parthenakis F,Boletis J,KarabinisA,et al.Adiponectin and cardiovascular remodeling in end2stage renal diseaseand co2morbid diabetes mellitus[J].Am J Nephrol,2006,26(4):340-347.
[47]Shibata R,Sato K,Pimentel DR,Takemura Y,Kihara S,Ohashi K,et al.Adiponectin protects against myocardial ischemia2reperfusion injury through AMPK2 and COX2-dependent mechanisms[J].Nat Med,2005,11(10):1 096-103.
[48]潘桂林,徐达华,高潮,等.冠心病患者中五心功能不全与合并心功能不全的脂联素水平观察[J].安徽医药,2008,12(1)
[49]刘岩,邹大进,李慧,等。低脂联素血症是冠状动脉粥样硬化严重程度的重要标志[J].中华内分泌代谢杂志,2005,21,21(1):5-8.
[50]Kistorp C,Faber J,Galatius S,et al.Plasma adiponectin,body mass index,and mortality in patientswith chronic heart failure[J].Circulation,2005,112(12):1756-62.
[51]Margaret B.McEntegart,Bonaventure Awede,Mark C.Petrie,et al.Increase in serum adiponectin concentration in patients with heart failure and cachexia:relationship with lep tin,other cytokines,and B- type natriuretic pep tide[J].European Heart Journal,2007,28(7):829-35.
[52]KintscherU.Does adiponectin resistance exist in chronic heart failure[J].Eur Heart J,2007,28(14):1676-1670.
[53]Bacci S,Menzaghi C,ErcolinoT,et al.The +276 G/T single nuclcotide polymorphism of the adiponectin gene is associated with coronary artery disease in type 2 diabetic patients.Diabetes Care,2004,27:2015-2020.
[54]Qi L,Li T,Rimm E.The +276 polymorphism of the APM1 gene,plasma adiponectin concentration,and cardiovascular risk in diabetic men.Diabetes,2005,54:1607-1610.
[55]Filippi E,Sentinelli F,Romeo S,et al.The adiponectin gene SNP+276G>T associates with early-onset coronary artery disease and with lower levels of adiponectin in younger coronary artery disease patients(age [56 Jung CH,Rhee EJ,Kim SY,et al.Associations between two single nucleotide polymorphisms of adiponectin gene and coronary artery diseases.Endocr J,2006,53:671-677.
[57]刘叶,于晓玲.不同类型冠心病患者血清脂联素水平及冠心病危险因素的变化.中国心血管病研究,2006,4:287-289.
[58]Ouchi N,Kiharn S,Amta Y,et al.Adiponectin,an adipocyte-derived plasma protein,inhibit s endot helial NF2κB signalingt hrough a cAMP2dependent pathway.Circulation,2000,102(11):1296-1301.
[59]Kumada M,Kihara S,Sumit suji S,et al.Association of hypoadiponectinemia wit h coronary artery disease in men.Arteriosc lerThromb Vasc Biol,2003,23(1):852 89.
[60]Nakamura Y,Shim ada K,Fukuda D,et al.Implications of plasma Concentions of adiponectin in patient s wit h coronary artery disease.Heart,2004,90(5):528-533.
[61]Nakamura Y,Shimada K,Fukuda D,et al.Implications of plasma concentrations of adiponectin in patients with coronary artery disease[J].Heart(British Cardiac Society),2004,90(5):528-533.
[62]Pischon T,Girman CJ,Hotamisligil GS,et al.Plasma adiponectin levels and risk of myocardial infarction in men[J].JAMA,2004,291(14):1730-1737.
[63]Zoccali C,Mallamaci F,Tripepi G,et al.Adiponectin,metabolic risk factors,and cardiovascular events among patients with end-stage renal disease[J].J Am Soc Nephrol,2002,13(1):134-141.
[64]Schulze MB,Shai I,Rimm EB,et al.Adiponectin and future coronary Heart disease events among men with type 2 diabetes[J].Diabetes,2005,54(2):534-539.
[65]Nakamura Y,Shimada K,Fukuda D,Shimada Y,Ehara S,Hirose M,et al.Implications of plasma concentrations of adiponectin in patients with coronary artery disease[J].Heart,2004,90(5):528-533.
[66]刘叶,于晓玲,不同类型冠心病患者血清脂联素水平及冠心病危险因素的变化,[J].中国心血管病研究杂志,2006,4(4):287-289
[67]Date H,Imamura T,Ideguchi T,Kawagoe J,Sumi T,Masuyama H,et al.Adiponectin produced in coronary circulation regulates coronary flow reserve innondiabetic patients with angiographically normal coronary arteries[J].ClinCardiol,2006,29(5):211-214.
[68]Zoccali C,Mallamaci F,Tripepi G.Adiponectin,metabolic risk factors,andcardiovascular events among patients with end2stage renal disease[J].J AmSoc Nephrol,2002,13(1):134-141.
[69]Kumada M,Kihara S,Ouchi N,et al.Adiponectin specifically increased tissue inhibitor of metalloproteinase21 through interleukin210 expression in human macrophages[J].Circulation,2004,109(17):2046-2049.
[70]Kojima S,Funahashi T,Sakamoto T,et al.The variation of plasma concentrations of a novel, adipocyte derived protein,adiponectin,in patients with acute myocardial infarction[J].Heart (British Cardiac Society),2003,89(6):667.
[71]洪洁,顾卫琼,张翼飞,等.胰岛素抵抗综合症患者血清脂联素和胰岛素敏感性的相关性研究[J].中华内分泌代谢杂志,2003,19,(3):173-176
[72]Yoshihisa O,Shinji K,Noriyuki O,et al.Adiponectin reduces atherosclerosisin apolipoprotein E2 deficient mice[J].Circulation,2002,106(22):2767-2770.
[73]Matsuda M,Shimomura I,Sata M.Role of adiponectin in preventing vascular stenosis.The missing link of adipo2vascular axis[J].J Biol Chem,2002,277(40):37487-37491
[2]Ishikawa Y,Akasaka Y,Ishii T,et al.Changes in the distribution pattern of gelatin2binding p rotein of 28 kda(adiponectin) in myocardial remodeling after ischaemic injury[J].Histopathology,2003,42(1):43.
[3]刘岩,邹大进,李慧,等.低脂联素血症是冠状动脉粥样硬化严重程度的重要标志[J].中华内分泌代谢杂志,2005,21(1:5-8)
[4]Pischon T,Girman CJ,Hotamisligil GS,et al.Plasma adiponectin levels and risk of myocardial infarction in men[J].JAMA,2004,291(14):1730-1737.
[5]KumadaM,Kihara S,Sumitsuji S,et al.Association of hypoadipone2Ctinemia with coronary artery disease in men[J].Arterioscler Thromb Vasc Biol,2003,23(1):85-89.
[6]胡大一.重视踝臂指数,关注下肢外周动脉病[J].中国医药导刊,2005,7(1):29.
[7]Kumada M,Kihara S,Sumitsuji S,et al.Association of hypoadiponettinemia with coronary artery disease in men[J].Arterioscler Thromb Vasc Biol,2003;23(1):85-9.
[8]郭杰,常志文。冠心病不同兵变支数与血清脂联素的相关性[J]。临床荟萃,2005;20(11):607-609。
[9]Kumada M,Kihara S,Ochi N,et al,Adioonectin specifically increased tissue inhibitor of metallo proteinase-1 through interleukin-10 expression in human macrophages[J].Circulation,2004;109(17):2046-9.
[10]Ouchi N,Kihara S,Arita Y,et al.Adiponectin,an adipocyte-derived plasma protein,inhibit s endothelial NF-kap-paB signaling through a cAMP-dependent pathway[J].Circulation,2000,102:1296
[11]Arita Y,Kihara S,Ouchi N,et al.Paradoxial decrease of an adipose spicific protein,adiponectin,in obesity[J].Biochem Biophys Res Commun,1999,257:79
[12]Yokota T,Oritani K,Takahashi I,et al.Adiponectin,a new member of the family of soluble defense collagens,negatively regulates the growth of myelomonocytic progenitiors and the functions of macrophages[J]Blood,2000,96:1723
[13]Ouchi N,Kihara S,Arita Y,et al.Adipoce-derived plasma protein,adiponectin,suppresses lipid accumulation and class A scavenger receptor expression in human monocyte2dedved macrophages[J].Circulation,2001,103:1057
[14]Mat suda M,Shimomural I,Sata M,et al.Role of adiponectin in preventing vascular stenosis:the missing linkof adipo-vascular axis[J].J Biol Chem.
[15]刘岩,邹大进,李慧,陈月,丁继军,郑兴,等.低脂联素血症是灌装动脉粥样硬化程度的重要标志[J].中华内分泌代谢杂志,2005,21(1):528
[16]Ouchi N,Kiharn S,Amta Y,et al.Adiponectin,an adipocyte-derived plasma protein,inhibit s endot helial NF2κB signalingt hrough a cAMP2dependent pathway.Circulation,2000,102(11):1296-1301
[17]Kumada M,Kihara S,Sumit suji S,et al.Association of hypoadiponectinemia wit h coronary artery disease in men.Arteriosc ler Thromb Vasc Biol,2003,23(1):85-89.
[18]Nakamura Y,Shim ada K,Fukuda D,et al.Implications of plasma concentions of adiponectin in patient s wit h coronary artery disease.Heart,2004,90(5):528-533.
[19]Nakamura Y,Shimada K,Fukuda D,et al.Implications of plasma concentrations of adiponectin in patients with coronary artery disease[J].Heart(British Cardiac Society),2004,90(5):5282533.
[20]Pischon T,Girman CJ,Hotamisligil GS,et al.Plasma adiponectin levels and risk of myocardial infarction in men[J].JAMA,2004,291(14):1730-1737.
[21]Zoccali C,Mallamaci F,Tripepi G,et al.Adiponectin,metabolic risk factors,and cardiovascular events among patients with end2stage renal disease[J].J Am Soc Nephrol,2002,13(1):134-141.
[22]Schulze MB,Shai I,Rimm EB,et al.Adiponectin and future coronary heart disease events among men with type 2 diabetes[J].Diabetes,2005,54(2):534-539.
[23]Nakamura Y,Shimada K,Fukuda D,Shimada Y,Ehara S,Hirose M,et al.Implications of plasma concentrations of adiponectin in patients with coronary artery disease[J].Heart,2004,90(5):528-533.
[24]刘叶,于晓玲,不同类型冠心病患者血清脂联素水平及冠心病危险因素的变化,[J].中国心血管病研究杂志,2006,4(4):287-289
[25]Date H,Imamura T,Ideguchi T,Kawagoe J,Sumi T,Masuyama H,et al.Adiponectin produced in coronary circulation regulates coronary flow reserve innondiabetic patients with angiographically normal coronary arteries[J].ClinCardiol,2006,29(5):211-214.
[26]BenetosA.Pulse p ressure and cardiovascular risk[J].JHyperLens,1999,17(supp 15):S21-24.
[27]胡大一,王宏宇.亚临床血管病变与临床实践(上)[J].中国医刊,2002,37(12):40-42.
[28]胡大一,王宏宇.亚临床血管病变与临床实践(下)[J].中国医刊,2003,38(1):52-54.
[29]Glasser SP,Amett DK,McVeigh GE,et al.Vascularcomp liance and cardiovascular disease:a risk factor ormarker[J].Am JHY - pertens,1997,10:1175-1189.
[30]Asmar R,Rudnichi A,Blacher J,et al.Pulse pressure and aortic pulsewave are markers of cardiovascular risk in hypertensive populations[J].AJH,2001,14:91-97.
[31]Zakopoulos NA,Lekakis JP,Papamichael CM,et al.Pulse pressure in normotensives:a marker of cardiovascular disease[J].Am J Hypertens, 2001,14(30):195-199.
[32]Yamashina A,Tomiyama H,Arai T,et al.Brachialankle pulse wave velocity as a marker of arherosclerotic vascular damage and ardiovascular risk[J].Hypertens Res,2003.26(8):615-622.
[33]Michael J,Domanski MD,Kim Sutton Tyrrell,et al.Determinant sand prognosticin formation provided by pulse pressure in patients with coronary artery disease under going revascularization(the balloon angio plasty revascularization investigation[J].Am J Cardiol,2001,87(6):675-679.
[34]Anar T,Ruidlavets J,Chamontin B,et al.Arterial stiffness and cardiovascular risk factors in a population based study[J].J Hypertens,2001,19(3):381-387
[35]Blather J,Asmar R,Djane S,et al.Aortic pulse wave velocity as a marker of cardiovascular risk in hypertension patients[J].Hypertension,1999,33:1111-1117.
[36]Meanme S,Benclos A,Hemv OF,et al.Aorlic pulse wave velocity predicts cardiovascular modality in subjects>70 years of age[J].Aterioscacler Thromb Vase Biol,2001,21(12):2046-2050.
[37]Blather J,Pannier B,Guerin AP,et al.CAROTID arterial stiffness as a predictor of cardiovascular and all cause mortality in end stage renal disease[J].Hypertension,1998,32(3):570-574
[38]Cleem JL.Executive summary of the third report of the National Cholesterol Education Program(NCEP) expert panel detection,evaluation,and treatment of high blood cholesterol in adults(adult treatment panel Ⅲ)[J].JAMA,2001,285(19):2486-2497.
[39]Abbott RD,Petrovich H,Rodriguez BL,et al.Ankle /brachial blood p ressure in men > 70years of age and the risk of coronary heart disease[J].Am J Cardiol,2000,86:280-284.
[40]Chuang SY,Chen CH,Cheng CM,et al.Combined ues of brachial2ankel pulse wave velocity and ankle2brachial index for fast assessment of arteriosclerosis and atherosclerosis in a community[J].Int J Cardiol,2005,98:99-105.
[41]王昆,胡大一,杨进刚,等.1 008例有心血管危险因素患者踝臂指数异常的发生率及其相关因素[J].首都医科大学学报,2006,27(4):4992511.
[42]韩雅蕾,胡大一.踝臂指数对冠心病患者冠状动脉粥样硬化及心血管事件的预测价值[J].中国民康医学杂志,2006,18:340-343.
[43]Lee AJ,Price JF,RussellMJ,et al.Imp roved p redition of fatalmyocardiaol infarction using the ankle brachial index in addition to conventional risk factors:The Edinburgh Artery Study[J].Circulation,2004,110:3075-3080.
[44]CriquiMH,Langer RD,Fronek A,et al.Mortality over a period of 10 year inpatientswith peripherial arterial disease[J].N Engl J Meal,1992,326:381-386.
[45]ChristosMP,Lekakis JP,Stamtelopoulos KS,et al.Ankle2brachial index as a predictor of the extent of coronary atherosclerosis and cardiovascular events in patientswith coronary artery disease[J].Am J Cardiol,2000,86:615-618.
[46]Kenneth E,AtulM,Eseroghene O,et al.U sefulness of an abnomal ankle-brachial index to p redict p resence of coronary artery disease in African-Americans[J].Am J Cardiol,2004,93:481-483.
[47]杨士伟,胡大一.踝臂指数对冠状动脉狭窄程度的预测价值[J].中国医药导刊,2006,8(2):79-82.
[48]Doobay AV,Anand SS.Sensitivity and specificity of the ankle2brachial index to predict future cardiovascular outcomes:a systematic review[J].Arterioscler Thromb Vasc B iol,2005,25:1463-1469.
[49]Hooi JD,Kester ADM,Stoffers HEJH,et al.Asymp tomatic peripheral arterial occlusive disease p redicted cardiovascular morbidity and mortality in a 72yearfollow-up study[J].J Clin Ep idemiol,2004,57:294-300.
[50]Resnick H,L indsay R.Relationship of high and low ankle2brachial index to all-cause and cardiovascular disease mortality[J].Circulation,2004,109:733-739.
[51]CriquiMH,Langer RD,Froneck A,et al.Mortality over a period of 10 years in patientswith peripheral arterial disease[J].N Engl J Med,1992,326:381-386.
[52]RutterMK,Wahid ST,McComb JM,et al.Significance of silent ischemia and microalbuminuria in p redicting coronary events in asymp tomatic patients with type 2diabetes[J].J Am Coll Cardiol,2002,40(1):56-61.
[53]CriquiMH,Fronek A,Barrett2Connor E,et al.The p revalence of peripheral arterial disease in a defined population[J].Circulation,1985,71:510-515.
[54]王宏宇,张维忠,龚兰生,等.脉搏波传导速度测定的新认识[J].国外医学.心血管疾病分册,2000,27(2):70-72.
[55]王国彦,胡大一.高血压患者大动脉弹性对冠状动脉血流储备的影响[J].中华医学杂志,2005,5(1):54-57.
[56]李佳月.脉搏波传导速度测定的临床意义[J].国际心血管病杂志,2006,33(2):91-93.
[57]MEAUME S,BENETOS A,HENRY O F,et al.Aortic pulse wave velocity predicts cardiovascular mortality in subjects> 70 years of age[J].Aterioscler Thromb Vase Biol,2001,21(12):2046- 2050.
[58]胡大一.重视踝臂指数,关注下肢外周动脉病[J].中国医药导刊,2005,7(1):29.
[1]李晓燕,王铁成,刘世雷.血浆脂联素与冠心病患者炎性因子水平的关系分析[J].中国心血管病研究,2007,5(8):584-585.
[2]李嘉强,戴颖秀,刘玉敏,等.高血压患者血浆脂联素与游离脂肪酸,糖及脂代谢[J].中华高血压杂志,2006,14:352-355
[3]TanKC,XuA,ChowWS,etal.Hypoadiponectinemiaisassociatedwithimpairedendothelium-depend entvasodilation[J].JClinEndocrinolMetab,2004,89:675-769
[4]KobayashiH,OuchiN,kiharaS,etal.Selectivesuppressionofendothelialcellapoptosisbythehighmol ecularweightformofadiponectin[J].CircRes,2004,94:E27-31
[5]YamauchiT,KamonJ,WakiH,etal.GluoaradiponectinprotectedobPobmicefromdiabetesandApoE -deficientmicefromatherosclerosis[J].JBiolChem,2003,278:2461-2468.
[6]Mat suzawa Y,Funahashi T,Nakamura T,et al.Molecularmechanism of metabolisyndrome of adipocytokines adipocyte-derived bioactive substances.Ann N Y Acad,1999,892:146-154.
[7]Maeda K,Okubo K,Shimomura I,Funahashi T,Matsuzawa Y,Matsubara K.cDNA cloning and expression of an novel adipose2specific collagen2like factorapM1(adipose most abundant gene transcript1)[J].Biochem Biophys Res Commun,1996,221(2):286-289.
[8]Hara K,Boutin P,Mori Y,Tobe K,Dina C,Yasuda K,et al.Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2diabetes in the Japanese Population[J].Diabetes,2002,51(2):536-540.
[9]Pajvani UB,Du X,Combs TP,et al.Structure function studies of the adipocyte-secreted hormone Acrp30Padiponectin:implications for metabolic-regulation and bioactivity[J].JBiol Chem,2003,278(11):9073-9085.
[10]Pajvani UB,HawkinsM,Combs TP,et al.Complex distribution,not absolute amount of adiponectin,correlates with thiazolidinedione-mediated improvement in insulin sensitivity[J].J Biol Chem,2004,279(13):12152-12162.
[11]Kobayashi H,Ouchi N,Kihara S,et al.Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin[J].Circ Res,2004,94(4):27-31.
[12]Aso Y,Yamamoto R,Wakabayashi S,Uchida T,Takayanagi K,Takebayashi K,et al.Comparison of serum high2molecular weight(HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme2linked immunosorbent assay to detect HMW adiponectin[J].Diabetes,2006,55(7):1954-960.
[13]Yamauch i T,Kamon J,Ito Y,et al.Cloning of adiponectin recep to rs that mediate antidiabetic metabo lic effects[J].N ature,2003,423(6941):762-769.
[14]Ohash i K,Ouch i N,Kihara S,etal.A diponectin I 164Tmutation is associated w ith the metabo lic syndrome and coronary artery disease[J].J Am Co 11 Cardio 1, 2004, 43 (7):1195-1200.
[15]Ouchi N , Kihara S , Funahashi T , et al.Reciprocal association of Creactive protein with adiponectin in bloodst ream and adipose tissue.Circulation , 2003 ,107 (5):671-674.
[16]Kato H , Kashiwagi H , Shiraga M ,et al.Adiponectin act s as an endogenous antit hrombotic factor.Arterioscl Thromb Vase Biol ,2006,26 (1):224-230.
[17]Hulthe J , Hulten LM, Fagerberg B.Low adipocyte2derived plasma protein adiponectin concentrations are associated with the metabolic syndrome and smalldense low-density lipoprotein particles:Atherosclerosis and insulin resistance study [J].Metabolism, 2003 ,52 (12):1 612-614.
[18]Maeda N,Shimomura I,Kishida K, Nishizawa H , Matsuda M, Nagaretani H ,et al.Diet-induced insulin resistance in mice lacking adiponectinPACRP30[J ].Nat Med , 2002 , 8:731-737.
[19]Hotta K, Funahashi T, Bodkin NL , Ortmeyer HK, Arita Y, Hansen BC, et al.Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys [J].Diabetes , 2001, 50:1126-133.
[20]Araki T, Emoto M, Teramura M, Yokoyama H , Mori K, Hatsuda S , et aLEffect of adiponectin on carotid arterial stiffness in type 2 diabetic patients treated with pioglitazone and metformin [J ].Metabolism , 2006 ,55 (8):996-1001.
[21]Iwaki M, Matsuda M, Maeda N , Funahashi T, Matsuzawa Y, Makishima M,et al.Induction of adiponectin ,a fat2derived antidiabetic and antiatherogenic factor , by nuclear receptors [J ].Diabetes, 2003 ,52 (7):1 655-663.
[22]Adamczak M, Wiecek A, Funahashi T, Chudek J , Kokot F, Matsuzawa Y.Decreased plasma adiponectin concentration in patients with essential hypertension [J ].Am J Hypertens , 2003 , 16 (1):72-75.
[23]Fasshauer M, Klein J , Neumann S , Eszlinger M, Paschke R.Adiponectin gene expression is inhibited by beta-adrenergic stimulation via protein kinase A in 3T32L1 adipocytes [J ].FEBS Lett, 2001,507 (2):142-146.
[24]Shimabukuro M, Higa N , Asahi T, Oshiro Y, Takasu N ,Tagawa T, et al.Hypoadiponectinemia is closely linked to endothelial dysfunction in man [J ].JClin Endocrinol Metab, 2003 ,88 (7):3 236-240.
[25]Otsuka F, Sugiyama S, Ko jima S, et al.Plasma adiponectin levels are associated w ith co ronary lesion comp lexity in men w ith co ronary artery disease[J ].J Am Coll Cardio 1; 2006, 48 (6):1155-1162.
[26]Kato H, Kash iwagi H, Sh iragaM , et al.A diponectin act as anendogenous antith rombo tic facto r [J ].A rterio scler Th romb V ascBio 1,2006,26 (1):224-230.
[27]马建林,李新明,王圣,等．不稳定型心绞痛患者体内凝血因子1的变化及意义[J]．临床 心血管病杂志,2006,22(2):121-122
[28]OUCHI N,KIHARA S,ARITA Y,et al.Adipocyte-derived plasma protein,adiponectin,suppresseslipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages[J].Circulation,2001,103:1057-1063.
[29]MATSUDA M,SHIMOMURA I,SATA M,et al.Role of adiponectin in preventing vascular senosin[J].J Biol Chem,2002,277:37487-37491.
[30]岳夏,吴华,陈新山.炎症与急性冠脉综合征的研究进展[J].临床心血管病杂志,2005,21(6):378-380
[31]Okamoto Y,Kihara S,Ouchi N,Nishida M,Arita Y,Kumada M,et al.Adiponectin reduces atherosclerosis in apolipoprotein Edeficient mice [J].Circulation,2002,106(22):2 767-770.
[32]FRUEBIS J,TSAO T S,JAVORSCHI S,et al.Proteolytic cleavage product of 302KDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice[J].Proc NatAcad Sci USA,2001,98:2005-2010.
[33]YAMAUCHI T,KAMON J,MIZO KOSHI Y,et al.Adiponectin stimulates glucose utilization and fattyacid oxidation by activating AMP2activated protein kinase[J].Nat Med,2002,8:1288-1295.
[34]YAMAUCHI T,KAMON J,WA KI H,et al.Globular adiponectin protected ob/ob mice f rom diabetesand Apo E2deficient mice from atherosclerosis[J].J Biol Chem,2003,278:2461-2468.
[35]Kawanam i D,M aemura K,Takeda N,et al.D irect recip rocal effects of resistin and adiponectin on vascular endo thelial cells:a new insigh t into adipocytok ineendo thelial cell interactions[J].Biochem Biophys Res Commun,2004,314:415-419.
[36]L in L Y,L in CY,Su TC,et al.A ngio tensin II induce dapop to sisin human endo thelial cells is inh ibited by p ro tein90[J].FEBS L ett,2004,574(13):106-110.
[37]M anigrasso MR,Ferroni P,Santilli F,et al.Association between circulating adiponectin and interleuk in210 levels in android obesity:effects of weigh t lo ss[J].J Clin Endocrino l M etab,2005,90:5876-5879.
[38]Wo lf AM,Wo lf D,Rumpo ld H,et al.A diponectin induces the anti inflammato ry cytokines IL 210 and IL 21RA in human leukocytes[J].Biochem Biophys Res Commun,2004,323:630.
[39]Peake PW,Shen Y,Campbell LV,et al.Human adiponectin binds to bacterial lipopo lysaccharide[J].Biochem Biophys Res Commun,2006,341(1):108-115.
[40]Ekmekci,H,Ekmekci,OB.The ro le of adiponectin in athero sclero sis and th rombosis[J].Clin-Appl-Thromb-Hemo st,2006,12(2):163-168.
[41]Okamo to Y,Kihaya S,Ouchi N,et al.A diponectin reduces athero sclero sis in apo lipop ro tein Edeficient m ice[J].Circulation,2002,106(22):2767-2770.
[42]Diep linger B,Poelz W,Haltmayer M,et al.Hypoadiponectinem ia is associated w ith symp tomatic athero sclero tic peripheral arterial disease[J].Clin Chem Lab Med,2006,44(7):830-833.
[43]Beh re CJ,Brohall G,Hulthe J,et al.A reserum adiponectin concentrations in a population samp le of 64-year-old Caucasian women w ith varying gluco seto lerance associated with ultrasound-assessed athero sclerosis[J].J Intern Med,2006,260(3):238-244.
[44]刘岩,邹大进,李慧,陈月,丁继军,郑兴,等.低脂联素血症是灌装动脉粥样硬化程度的重要标志[J].中华内分泌代谢杂志,2005,21(1):5-8
[45]Ishikawa Y,Akasaka Y,Ishii T,Yoda Murakami M,Choi Miura NH,Tomita M,et al.Changes in the distribution pattern of gelatin -binding protein of 28kDa(adiponectin) in myocardial remodelling after ischaemic injury[J].Histopathology,2003,42(1):43-52.
[46]Karakitsos D,De Groot E,Patrianakos AP,Parthenakis F,Boletis J,KarabinisA,et al.Adiponectin and cardiovascular remodeling in end2stage renal diseaseand co2morbid diabetes mellitus[J].Am J Nephrol,2006,26(4):340-347.
[47]Shibata R,Sato K,Pimentel DR,Takemura Y,Kihara S,Ohashi K,et al.Adiponectin protects against myocardial ischemia2reperfusion injury through AMPK2 and COX2-dependent mechanisms[J].Nat Med,2005,11(10):1 096-103.
[48]潘桂林,徐达华,高潮,等.冠心病患者中五心功能不全与合并心功能不全的脂联素水平观察[J].安徽医药,2008,12(1)
[49]刘岩,邹大进,李慧,等。低脂联素血症是冠状动脉粥样硬化严重程度的重要标志[J].中华内分泌代谢杂志,2005,21,21(1):5-8.
[50]Kistorp C,Faber J,Galatius S,et al.Plasma adiponectin,body mass index,and mortality in patientswith chronic heart failure[J].Circulation,2005,112(12):1756-62.
[51]Margaret B.McEntegart,Bonaventure Awede,Mark C.Petrie,et al.Increase in serum adiponectin concentration in patients with heart failure and cachexia:relationship with lep tin,other cytokines,and B- type natriuretic pep tide[J].European Heart Journal,2007,28(7):829-35.
[52]KintscherU.Does adiponectin resistance exist in chronic heart failure[J].Eur Heart J,2007,28(14):1676-1670.
[53]Bacci S,Menzaghi C,ErcolinoT,et al.The +276 G/T single nuclcotide polymorphism of the adiponectin gene is associated with coronary artery disease in type 2 diabetic patients.Diabetes Care,2004,27:2015-2020.
[54]Qi L,Li T,Rimm E.The +276 polymorphism of the APM1 gene,plasma adiponectin concentration,and cardiovascular risk in diabetic men.Diabetes,2005,54:1607-1610.
[55]Filippi E,Sentinelli F,Romeo S,et al.The adiponectin gene SNP+276G>T associates with early-onset coronary artery disease and with lower levels of adiponectin in younger coronary artery disease patients(age
[57]刘叶,于晓玲.不同类型冠心病患者血清脂联素水平及冠心病危险因素的变化.中国心血管病研究,2006,4:287-289.
[58]Ouchi N,Kiharn S,Amta Y,et al.Adiponectin,an adipocyte-derived plasma protein,inhibit s endot helial NF2κB signalingt hrough a cAMP2dependent pathway.Circulation,2000,102(11):1296-1301.
[59]Kumada M,Kihara S,Sumit suji S,et al.Association of hypoadiponectinemia wit h coronary artery disease in men.Arteriosc lerThromb Vasc Biol,2003,23(1):852 89.
[60]Nakamura Y,Shim ada K,Fukuda D,et al.Implications of plasma Concentions of adiponectin in patient s wit h coronary artery disease.Heart,2004,90(5):528-533.
[61]Nakamura Y,Shimada K,Fukuda D,et al.Implications of plasma concentrations of adiponectin in patients with coronary artery disease[J].Heart(British Cardiac Society),2004,90(5):528-533.
[62]Pischon T,Girman CJ,Hotamisligil GS,et al.Plasma adiponectin levels and risk of myocardial infarction in men[J].JAMA,2004,291(14):1730-1737.
[63]Zoccali C,Mallamaci F,Tripepi G,et al.Adiponectin,metabolic risk factors,and cardiovascular events among patients with end-stage renal disease[J].J Am Soc Nephrol,2002,13(1):134-141.
[64]Schulze MB,Shai I,Rimm EB,et al.Adiponectin and future coronary Heart disease events among men with type 2 diabetes[J].Diabetes,2005,54(2):534-539.
[65]Nakamura Y,Shimada K,Fukuda D,Shimada Y,Ehara S,Hirose M,et al.Implications of plasma concentrations of adiponectin in patients with coronary artery disease[J].Heart,2004,90(5):528-533.
[66]刘叶,于晓玲,不同类型冠心病患者血清脂联素水平及冠心病危险因素的变化,[J].中国心血管病研究杂志,2006,4(4):287-289
[67]Date H,Imamura T,Ideguchi T,Kawagoe J,Sumi T,Masuyama H,et al.Adiponectin produced in coronary circulation regulates coronary flow reserve innondiabetic patients with angiographically normal coronary arteries[J].ClinCardiol,2006,29(5):211-214.
[68]Zoccali C,Mallamaci F,Tripepi G.Adiponectin,metabolic risk factors,andcardiovascular events among patients with end2stage renal disease[J].J AmSoc Nephrol,2002,13(1):134-141.
[69]Kumada M,Kihara S,Ouchi N,et al.Adiponectin specifically increased tissue inhibitor of metalloproteinase21 through interleukin210 expression in human macrophages[J].Circulation,2004,109(17):2046-2049.
[70]Kojima S,Funahashi T,Sakamoto T,et al.The variation of plasma concentrations of a novel, adipocyte derived protein,adiponectin,in patients with acute myocardial infarction[J].Heart (British Cardiac Society),2003,89(6):667.
[71]洪洁,顾卫琼,张翼飞,等.胰岛素抵抗综合症患者血清脂联素和胰岛素敏感性的相关性研究[J].中华内分泌代谢杂志,2003,19,(3):173-176
[72]Yoshihisa O,Shinji K,Noriyuki O,et al.Adiponectin reduces atherosclerosisin apolipoprotein E2 deficient mice[J].Circulation,2002,106(22):2767-2770.
[73]Matsuda M,Shimomura I,Sata M.Role of adiponectin in preventing vascular stenosis.The missing link of adipo2vascular axis[J].J Biol Chem,2002,277(40):37487-37491